X4 Pharmaceuticals Inc (XFOR)
0.9597
-0.02
(-1.69%)
USD |
NASDAQ |
May 16, 16:00
0.95
-0.01
(-1.01%)
After-Hours: 20:00
X4 Pharmaceuticals Cash from Operations (TTM): -103.60M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -103.60M |
| December 31, 2023 | -96.51M |
| September 30, 2023 | -87.86M |
| June 30, 2023 | -86.34M |
| March 31, 2023 | -83.38M |
| December 31, 2022 | -77.10M |
| September 30, 2022 | -77.06M |
| June 30, 2022 | -71.97M |
| March 31, 2022 | -72.69M |
| December 31, 2021 | -70.90M |
| September 30, 2021 | -69.36M |
| June 30, 2021 | -69.47M |
| March 31, 2021 | -61.74M |
| Date | Value |
|---|---|
| December 31, 2020 | -58.82M |
| September 30, 2020 | -50.56M |
| June 30, 2020 | -49.00M |
| March 31, 2020 | -51.83M |
| December 31, 2019 | -48.06M |
| September 30, 2019 | -30.42M |
| June 30, 2019 | -25.80M |
| March 31, 2019 | -24.99M |
| December 31, 2018 | -25.42M |
| September 30, 2018 | -46.72M |
| June 30, 2018 | -43.65M |
| March 31, 2018 | -36.54M |
| December 31, 2017 | -27.87M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-103.60M
Minimum
Mar 2024
-25.80M
Maximum
Jun 2019
-67.12M
Average
-70.19M
Median
Cash from Operations (TTM) Benchmarks
| Phio Pharmaceuticals Corp | -10.05M |
| Ocular Therapeutix Inc | -84.15M |
| Alpine Immune Sciences Inc | -80.55M |
| Scholar Rock Holding Corp | -151.96M |
| RAPT Therapeutics Inc | -105.53M |